Virtus LifeSci Biotech Clinical Trials ETF (BBC) Holdings $16.40 -0.85 (-4.93%) As of 04:10 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsRatingsBuy This Stock Top 50 BBC HoldingsRankCompanyCurrent PriceWeightShares Held1XERSXeris Biopharma$4.91-4.7%1.88%48,2882SLNOSoleno Therapeutics$72.49-1.6%1.80%3,5433AKROAkero Therapeutics$41.01-2.2%1.62%5,6544LQDALiquidia$14.15-2.5%1.56%14,9105MLYSMineralys Therapeutics$13.18-5.9%1.52%13,4946ARQTArcutis Biotherapeutics$16.04-3.4%1.49%13,4017ANABAnaptysBio$18.85-0.6%1.44%10,9268PTGXProtagonist Therapeutics$46.35-3.8%1.40%4,0659SMMTSummit Therapeutics$18.93-7.5%1.26%9,19210BLTEBelite Bio$64.40-1.5%1.22%2,589 Get the Latest News and Ratings for BBC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE daily newsletter. 11MRUSMerus$43.12+0.3%1.19%3,96712ABUSArbutus Biopharma$3.38-3.7%1.14%46,11413OMEROmeros$7.37-8.0%1.13%19,33814ZYMEZymeworks$11.96+0.3%1.10%13,00615ETNB89bio$6.91-3.9%1.08%20,91216SNDXSyndax Pharmaceuticals$12.60-2.9%1.06%12,19217PRTAProthena$11.43-5.8%1.04%11,89118RNAAvidity Biosciences$28.52-4.2%1.02%4,86019VIRVir Biotechnology$5.91-8.8%1.02%22,09320CVACCureVac$2.88+0.7%1.01%51,29621ELVNEnliven Therapeutics$19.70-0.8%1.00%7,14222CNTACentessa Pharmaceuticals$13.19-3.7%0.99%9,73323CGONCG Oncology$19.23-13.5%0.99%5,68624XENEXenon Pharmaceuticals$31.53+0.2%0.99%4,16125APGEApogee Therapeutics$34.94-7.6%0.98%3,70126LENZLENZ Therapeutics$23.08-9.5%0.97%5,33427MNMDMind Medicine (MindMed)$5.70-4.5%0.97%23,38828PHVSPharvaris$15.11+1.1%0.96%8,63629RGNXREGENXBIO$6.60-6.4%0.96%18,83030SANASana Biotechnology$1.48-9.2%0.96%80,46731SVRASavara$2.91-3.3%0.96%49,00632NAMSNewAmsterdam Pharma$17.35-4.7%0.95%6,54333NUVLNuvalent$68.77-2.4%0.95%1,89034CELCCelcuity$9.23-1.4%0.93%13,02035CYTKCytokinetics$41.16+2.3%0.93%3,27036REPLReplimune Group$7.99-7.3%0.93%13,43437ACLXArcellx$63.91-4.9%0.92%1,96838RVMDRevolution Medicines$33.44-3.4%0.92%3,65239EWTXEdgewise Therapeutics$13.42-13.5%0.91%5,82940DNTHDianthus Therapeutics$16.20-9.3%0.90%6,986Trump Treasure April 19 (Ad)Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…If I’m right about this (like I was before) a modest $900 investment…41IRONDisc Medicine$46.62-3.9%0.90%2,55642SRRKScholar Rock$31.52-3.1%0.90%3,93943ABCLAbCellera Biologics$2.11-5.0%0.88%55,64544ITOSiTeos Therapeutics$5.83+1.0%0.88%20,66345RXRXRecursion Pharmaceuticals$4.94-6.6%0.88%23,51846VRDNViridian Therapeutics$12.50-4.4%0.87%9,12947Bny Mellon Cash Reserve UsdN/A0.86%120,73948MLTXMoonLake Immunotherapeutics$37.52-1.4%0.85%3,05049VERVVerve Therapeutics$3.90-0.3%0.85%26,34850ALLOAllogene Therapeutics$1.42-1.4%0.84%81,270 Related Companies and Tools Related Companies FTXH Portfolio MEDI Portfolio MEDX Portfolio PILL Portfolio GDOC Portfolio BBP Portfolio JDOC Portfolio HYLG Portfolio BIS Portfolio LGHT Portfolio This page (NYSEARCA:BBC) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredIt’s Time to Buy Elon’s “ChatGPT Killer”Elon Musk’s new AI model is blowing everyone’s mind. It has been called “a game-changer in AI innovation”.....Brownstone Research | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredWhy Elon Musk Is Investigating Fort KnoxWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Clinical Trials ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BBC Stock Free BBC Stock Alerts